 |
|
Home | 4s3 Bioscience, Inc. Secures $20M in Series A Financing |
 |
4s3 Bioscience, Inc. Secures $20M in Series A Financing
|
 |
- March 07, 2012
-
4s3 Bioscience, Inc. (4s3), a privately-held biotherapeutics company focused on developing genetic disease therapies for orphan neuromuscular disorders announced today the closing of a $20 million Series A financing with KLP Enterprises, LLC (KLP). Medford, Mass. (PRWEB) March 07, 2012 4s3 Bioscience, Inc. (4s3), a privately-held biotherapeutics company focused on developing genetic disease therapies for [...]This article (4s3 Bioscience, Inc. Secures $20M in Series A Financing) was originally developed by and is property of American Banking News. Checkout American Banking News for up-to-date banking news and peer to peer lending news.
- Read more at:http://www.americanbankingnews.com/2012/03/07/4s3-bioscience-inc-secures-20m-in-series-a-financing/
|
 |
|
 |
|
 |
